Human CCL21/6Ckine Antibody, R&D Systems™

CCL21/6Ckine

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

6Ckine, 6CkineSmall-inducible cytokine A21, Beta-chemokine exodus-2, chemokine (C-C motif) ligand 21, CKb9, exodus-2, member 21, SCYA21, SCYA21MGC34555, secondary lymphoid tissue chemokine, SLC, SLCSecondary lymphoid-tissue chemokine, TCA-4

Mouse

Protein A or G purified from ascites

RUO

6366

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1

Western Blot

54125

Western Blot 1 ug/mL

O00585

CCL21

E. coli-derived recombinant human CCL21/6Ckine Ser24-Pro134 Accession # O00585

25 μg

Primary

Detects human CCL21/6Ckine in direct ELISAs and Western blots. Does not cross-react with recombinant mouse (rm) CCL21, recombinant human (rh) MCP-1, rhMCP-2, rhMCP-3, rhMCP-4, rmMCP-5, rhMIP-1 alpha , rmMIP-1 alpha , rhMIP-1 beta , rmMIP-1 beta , rhMIP-1 delta , rmMIP-1 gamma , rmMIP-2, rhMIP-3 alpha , rmMIP-3 alpha , rrMIP-3 alpha , rhMIP-3 beta , rmMIP-3 beta , or rmCCL7.

Human

Purified